We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$10.9B
AUM Growth
+$433M
Cap. Flow
+$143M
Cap. Flow %
1.31%
Top 10 Hldgs %
18.12%
Holding
2,433
New
160
Increased
1,129
Reduced
851
Closed
234
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLNE icon
2151
Clean Energy Fuels
CLNE
$386M
$40K ﹤0.01%
14,849
+300
+2% +$872
INO icon
2152
Inovio Pharmaceuticals
INO
$82.5M
$38K ﹤0.01%
1,066
WPRT
2153
Westport Fuel Systems
WPRT
$35.7M
$38K ﹤0.01%
1,406
+120
+9% +$2.67K
NBR icon
2154
Nabors Industries
NBR
$1.33B
$36K ﹤0.01%
251
-9
-3% -$1.44K
XXII
2155
22nd Century Group
XXII
$1.5M
0
PLUG icon
2156
Plug Power
PLUG
$3.46B
$35K ﹤0.01%
15,436
-5,335
-26% -$13.2K
RMTI icon
2157
Rockwell Medical
RMTI
$27.2M
$35K ﹤0.01%
105
EXK
2158
Endeavour Silver
EXK
$3.02B
$34K ﹤0.01%
16,677
HMY icon
2159
Harmony Gold Mining
HMY
$12.2B
$34K ﹤0.01%
+15,075
New +$27.8K
RKDA icon
2160
Arcadia Biosciences
RKDA
$1.44M
$34K ﹤0.01%
+275
New +$58.5K
CRNT icon
2161
Ceragon Networks
CRNT
$215M
$33K ﹤0.01%
+11,235
New +$36.8K
IDXG
2162
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$32K ﹤0.01%
4,475
+2,215
+98% +$16.2K
CARM
2163
DELISTED
Carisma Therapeutics
CARM
$31K ﹤0.01%
+1,045
New +$31.3K
OPCH icon
2164
Option Care Health
OPCH
$3.67B
$31K ﹤0.01%
2,947
+216
+8% +$1.77K
MBVX
2165
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
$29K ﹤0.01%
+582,855
New +$29K
FTR
2166
DELISTED
Frontier Communications Corp.
FTR
$28K ﹤0.01%
16,106
-5,441
-25% -$11.1K
GERN icon
2167
Geron
GERN
$962M
$27K ﹤0.01%
19,045
IGC icon
2168
IGC Pharma
IGC
$28.8M
$27K ﹤0.01%
16,640
+100
+0.6% +$141
TURN
2169
DELISTED
180 Degree Capital
TURN
$25K ﹤0.01%
4,308
MNDO icon
2170
Mind CTI
MNDO
$20.6M
$24K ﹤0.01%
+10,800
New +$23.4K
TMDI
2171
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$24K ﹤0.01%
+10,381
New +$26K
PLM
2172
DELISTED
PolyMet Mining Corp.
PLM
$20K ﹤0.01%
4,609
HL icon
2173
Hecla Mining
HL
$11.7B
$19K ﹤0.01%
10,804
-1,100
-9% -$2.01K
FCSC
2174
DELISTED
Fibrocell Science Inc.
FCSC
$19K ﹤0.01%
10,016
TGB
2175
Trekor Metals
TGB
$3.23B
$17K ﹤0.01%
31,350

Similar funds

Cambridge Investment Research Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Cambridge Investment Research Advisors held 2,433 positions worth $10.9B, up 4.1% from $10.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2019 filing shows 160 new, 1,129 increased, 851 reduced and 234 closed positions. Its largest new stake was WisdomTree International ESG Fund: 441,613 shares worth $10.6M. The largest sale was Vanguard S&P 500 ETF, an estimated $38M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2019 buy was WisdomTree International ESG Fund: 441,613 shares worth $10.6M.
  • Cambridge Investment Research Advisors added most to Vanguard Short-Term Treasury ETF in Q2 2019, an estimated $27M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2019 reduction was Vanguard S&P 500 ETF, cutting an estimated $38M.
  • Cambridge Investment Research Advisors fully exited DuPont de Nemours in Q2 2019, selling an estimated $17.5M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $10.9B portfolio in Q2 2019.
  • Cambridge Investment Research Advisors opened 160 new positions and closed 234 in Q2 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 4.1% quarter-over-quarter to $10.9B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2019, filed 15 Aug 2019.